First Mercantile Trust Co. lessened its position in Natus Medical Inc (NASDAQ:BABY) by 17.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 10,744 shares of the medical equipment provider’s stock after selling 2,207 shares during the quarter. First Mercantile Trust Co.’s holdings in Natus Medical were worth $410,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently bought and sold shares of BABY. Alliancebernstein L.P. increased its position in Natus Medical by 2.3% during the 2nd quarter. Alliancebernstein L.P. now owns 53,756 shares of the medical equipment provider’s stock valued at $2,005,000 after buying an additional 1,190 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Natus Medical by 0.6% in the 2nd quarter. BlackRock Inc. now owns 4,149,535 shares of the medical equipment provider’s stock worth $154,779,000 after purchasing an additional 25,340 shares in the last quarter. New York State Common Retirement Fund increased its holdings in shares of Natus Medical by 7.3% in the 2nd quarter. New York State Common Retirement Fund now owns 82,018 shares of the medical equipment provider’s stock worth $3,059,000 after purchasing an additional 5,571 shares in the last quarter. Northern Trust Corp increased its holdings in shares of Natus Medical by 2.2% in the 2nd quarter. Northern Trust Corp now owns 518,499 shares of the medical equipment provider’s stock worth $19,341,000 after purchasing an additional 11,036 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of Natus Medical by 2.9% in the 2nd quarter. Vanguard Group Inc. now owns 2,341,546 shares of the medical equipment provider’s stock worth $87,340,000 after purchasing an additional 66,676 shares in the last quarter. 99.64% of the stock is owned by institutional investors.
A number of analysts have commented on the company. Zacks Investment Research raised Natus Medical from a “hold” rating to a “buy” rating and set a $45.00 target price for the company in a report on Tuesday, October 24th. William Blair lowered Natus Medical from an “outperform” rating to a “market perform” rating in a report on Monday, January 8th. Benchmark reaffirmed a “buy” rating and issued a $49.00 price objective (down previously from $55.00) on shares of Natus Medical in a report on Tuesday, January 16th. Finally, BidaskClub lowered Natus Medical from a “hold” rating to a “sell” rating in a report on Saturday, December 9th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and one has assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $47.00.
Natus Medical Inc (NASDAQ BABY) traded up $0.75 during midday trading on Friday, reaching $30.85. The company had a trading volume of 370,707 shares, compared to its average volume of 569,755. The stock has a market capitalization of $961.10, a P/E ratio of -49.76 and a beta of 0.56. The company has a quick ratio of 2.54, a current ratio of 3.32 and a debt-to-equity ratio of 0.37. Natus Medical Inc has a 12 month low of $28.00 and a 12 month high of $43.60.
Natus Medical (NASDAQ:BABY) last released its earnings results on Wednesday, February 7th. The medical equipment provider reported $0.42 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.54 by ($0.12). Natus Medical had a negative net margin of 4.05% and a positive return on equity of 11.36%. The company had revenue of $131.40 million for the quarter, compared to analysts’ expectations of $131.38 million. During the same quarter last year, the firm posted $0.51 earnings per share. Natus Medical’s revenue for the quarter was up 22.0% on a year-over-year basis. sell-side analysts anticipate that Natus Medical Inc will post 1.63 earnings per share for the current fiscal year.
About Natus Medical
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.